Journal of Southern Medical University ›› 2023, Vol. 43 ›› Issue (8): 1356-1362.doi: 10.12122/j.issn.1673-4254.2023.08.12

Previous Articles     Next Articles

Curcumin suppresses proliferation, migration and invasion of papillary thyriod cancer B-CPAP cells through the Keap1-Nrf2 pathway

REN Li, ZOU Mingyuan, ZHU Xingchun, XU Wenjun, LIU Gang, SUN Junjie, FAN Fangtian, ZHANG Congli   

  1. School of Laboratory Medicine, School of Clinical Medicine, Anhui Provincial Key Laboratory of Cancer Translational Medicine, School of Pharmacy/Anhui Biochemical Pharmaceutical Engineering Technology Research Center, Bengbu Medical College, Bengbu 233030, China; Department of Anesthesia, First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China
  • Online:2023-08-20 Published:2023-09-13

Abstract: Objective To observe the effects of curcumin on migration and invasion of papillary thyriod cancer B-CPAP cells. Methods B-CPAP cells were treated with 5, 10, 15, or 20 μmol/L curcumin, and the changes in cell survival, migration and invasion were examined using MTT assay and Transwell assay. ROS levels in the treated cells were detected with a DCFH-DA probe. The expression levels of Nrf2 and Keap1 in the cells were determined using Western blotting and qRT-PCR. Results Treatment with curcumin dose- and time-dependently suppressed the viability of B-CPAP cells (P<0.05 or P<0.01). Curcumin inhibited the migration and invasion (P<0.001) and promoted ROS production in B-CPAP cells in a dose-dependent manner, and application of NAC effectively reversed curcumin- induced increase of ROS. Curcumin at 20 μmol/L significantly decreased the protein and mRNA expressions of Nrf2 and increased the expressions of Keap1 protein and mRNA (P<0.05 or P<0.01), causing also significantly reduced expression of Nrf2 protein in the cell nuclei (P<0.05) without obviously affecting its expression in the cytoplasm (P>0.05). Conclusion Curcumin inhibits the proliferation, migration and invasion of papillary thyriod cancer B-CPAP cells probably via the Keap1-Nrf2 signaling pathway.

Key words: curcumin; B-CPAP; Keap1-Nrf2 pathway; papillary thyriod cancer